Figure 1.
The effects of OLZ and CLZ treatment on (A) body mass, (B) food intake, (C) WAT, (D) liver and (E) feeding efficiency (gram weight gain/gram food intake). Rats were administrated orally with OLZ (3 mg/kg, b.i.d), CLZ (20 mg/kg, b.i.d) or vehicle for 9 weeks. Data are presented as mean ± SEM (n = 12 per group). *p < 0.05, **p < 0.01 and ***p < 0.001: OLZ treatment vs. control, # p < 0.05, ## p < 0.01 and ### p < 0.001: CLZ treatment vs. control. BWG: body weight gain; CFI: cumulative food intake; WAT: white adipose tissue, including perirenal, periovary, inguinal, and mesentery fat; C: control; OLZ: olanzapine; CLZ: clozapine.